Publication Information

{'id': 'https://openalex.org/W4282970146', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-1859', 'title': 'Abstract 1859: VIP152, a selective CDK9 inhibitor, demonstrates sensitivity in gynecologic cell lines that are cisplatin sensitive or resistant and delivers <i>in vivo</i> antitumor efficacy', 'display_name': 'Abstract 1859: VIP152, a selective CDK9 inhibitor, demonstrates sensitivity in gynecologic cell lines that are cisplatin sensitive or resistant and delivers <i>in vivo</i> antitumor efficacy', 'publication_year': 2022, 'publication_date': '2022-06-15', 'ids': {'openalex': 'https://openalex.org/W4282970146', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-1859'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-1859', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5021503872', 'display_name': 'Melanie M. Frigault', 'orcid': 'https://orcid.org/0009-0002-8525-4239'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Melanie M. Frigault', 'raw_affiliation_strings': ['1Vincerx Pharma, Inc., Palo Alto, CA;'], 'affiliations': [{'raw_affiliation_string': '1Vincerx Pharma, Inc., Palo Alto, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009014777', 'display_name': 'Hermes Garbán', 'orcid': 'https://orcid.org/0000-0001-7754-5357'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Hermes Garban', 'raw_affiliation_strings': ['1Vincerx Pharma, Inc., Palo Alto, CA;'], 'affiliations': [{'raw_affiliation_string': '1Vincerx Pharma, Inc., Palo Alto, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089115545', 'display_name': 'Joy M. Greer', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Joy M. Greer', 'raw_affiliation_strings': ['1Vincerx Pharma, Inc., Palo Alto, CA;'], 'affiliations': [{'raw_affiliation_string': '1Vincerx Pharma, Inc., Palo Alto, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039172611', 'display_name': 'Stuart Hwang', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Stuart Hwang', 'raw_affiliation_strings': ['1Vincerx Pharma, Inc., Palo Alto, CA;'], 'affiliations': [{'raw_affiliation_string': '1Vincerx Pharma, Inc., Palo Alto, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029736763', 'display_name': 'Raquel Izumi', 'orcid': 'https://orcid.org/0000-0002-0895-2597'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Raquel Izumi', 'raw_affiliation_strings': ['1Vincerx Pharma, Inc., Palo Alto, CA;'], 'affiliations': [{'raw_affiliation_string': '1Vincerx Pharma, Inc., Palo Alto, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021564306', 'display_name': 'Amy J. Johnson', 'orcid': 'https://orcid.org/0000-0002-0306-4646'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Amy J. Johnson', 'raw_affiliation_strings': ['1Vincerx Pharma, Inc., Palo Alto, CA;'], 'affiliations': [{'raw_affiliation_string': '1Vincerx Pharma, Inc., Palo Alto, CA;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040976235', 'display_name': 'Beatrix Stelte‐Ludwig', 'orcid': 'https://orcid.org/0000-0002-1045-1134'}, 'institutions': [], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Beatrix Stelte-Ludwig', 'raw_affiliation_strings': ['2Vincerx Pharma, GmbH, Monheim, Germany.'], 'affiliations': [{'raw_affiliation_string': '2Vincerx Pharma, GmbH, Monheim, Germany.', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5067807887', 'display_name': 'Ahmed Hamdy', 'orcid': 'https://orcid.org/0009-0008-7188-4188'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Ahmed Hamdy', 'raw_affiliation_strings': ['1Vincerx Pharma, Inc., Palo Alto, CA;'], 'affiliations': [{'raw_affiliation_string': '1Vincerx Pharma, Inc., Palo Alto, CA;', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.374, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.55979, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 62, 'max': 72}, 'biblio': {'volume': '82', 'issue': '12_Supplement', 'first_page': '1859', 'last_page': '1859'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10550', 'display_name': 'Genomic Studies and Treatment of Ovarian Carcinoma', 'score': 0.8778, 'subfield': {'id': 'https://openalex.org/subfields/2743', 'display_name': 'Reproductive Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10550', 'display_name': 'Genomic Studies and Treatment of Ovarian Carcinoma', 'score': 0.8778, 'subfield': {'id': 'https://openalex.org/subfields/2743', 'display_name': 'Reproductive Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11287', 'display_name': 'Genomic Landscape of Cancer and Mutational Signatures', 'score': 0.8244, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tumor-models', 'display_name': 'Tumor Models', 'score': 0.462421}], 'concepts': [{'id': 'https://openalex.org/C2778239845', 'wikidata': 'https://www.wikidata.org/wiki/Q412415', 'display_name': 'Cisplatin', 'level': 3, 'score': 0.700545}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.6409377}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.6407112}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.56369346}, {'id': 'https://openalex.org/C2780427987', 'wikidata': 'https://www.wikidata.org/wiki/Q172341', 'display_name': 'Ovarian cancer', 'level': 3, 'score': 0.54430634}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.4582069}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.43323153}, {'id': 'https://openalex.org/C150194340', 'wikidata': 'https://www.wikidata.org/wiki/Q26972', 'display_name': 'Gene expression', 'level': 3, 'score': 0.41297862}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.37446675}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.3363662}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.28177392}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.18001753}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.13275713}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-1859', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.85, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4385496679', 'https://openalex.org/W2407812582', 'https://openalex.org/W2406608798', 'https://openalex.org/W2406596433', 'https://openalex.org/W2390799392', 'https://openalex.org/W2149068418', 'https://openalex.org/W2091461259', 'https://openalex.org/W2080420195', 'https://openalex.org/W2066496973', 'https://openalex.org/W2053306150'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'The': [2], 'Myc': [3, 76], 'transcription': [4, 74], 'factor': [5], 'has': [6], 'a': [7, 81, 165, 181, 235, 316, 393], 'short': [8], 'half-life': [9], 'of': [10, 27, 34, 67, 75, 97, 110, 134, 160, 176, 184, 263, 293, 418], '20-30': [11], 'minutes': [12], '(Ramsay': [13], 'et': [14, 30, 87, 348, 358, 366], 'al.': [15, 31, 349, 359, 367], '1984)': [16], 'and': [17, 20, 43, 60, 114, 197, 224, 308, 344, 409], 'oncogenic': [18], 'activation': [19, 35], 'transcriptional': [21], 'addiction': [22], 'leads': [23], 'to': [24, 47, 90, 140, 144, 216, 241, 271, 311], 'sustained': [25], 'levels': [26, 109, 268], 'Myc,': [28], '(Gabay': [29], '2014).': [32], 'Mechanisms': [33], 'include': [36], 'MYC': [37], 'gene': [38, 151, 236, 298], 'amplification,': [39], 'mutation': [40], 'or': [41, 153, 214, 407], 'rearrangement': [42], 'have': [44], 'been': [45], 'reported': [46], 'be': [48], 'prevalent': [49], 'in': [50, 94, 164, 169, 201, 210, 243, 249, 254, 288, 325, 327, 338, 399, 411], 'gynecologic': [51, 98, 177, 244, 289, 400], 'malignancies,': [52], 'such': [53], 'as': [54, 116, 222], 'serous': [55], 'ovarian': [56, 251], '(39.2%),': [57], 'uterine': [58], '(28.1%)': [59], 'endometrial': [61], '(19.5%)': [62], '(https://www.cancer.gov/tcga).': [63], 'Since': [64], 'CDK9': [65, 84, 395], 'phosphorylation': [66], 'RNA': [68], 'polymerase': [69], 'II': [70], 'is': [71, 146, 301, 331, 334], 'required': [72], 'for': [73, 422], 'mRNA,': [77], 'we': [78, 309], 'evaluate': [79], 'VIP152,': [80, 392], 'highly': [82], 'selective': [83, 394], 'inhibitor': [85], '(Lücking': [86], 'al': [88], '2021),': [89], 'deliver': [91], 'antitumor': [92, 413], 'responses': [93], 'preclinical': [95], 'models': [96], 'malignancies.': [99, 245], 'Methods:': [100], 'Gynecologic': [101], 'cell': [102, 124, 136, 178, 199, 211, 290, 318, 401], 'lines': [103, 137, 179, 200, 212, 219, 291, 402], 'were': [104, 119, 208, 220], 'treated': [105], 'with': [106, 112, 148, 186, 260, 281, 303, 315], '9': [107], 'dose': [108, 267], 'VIP152': [111, 145, 161, 187, 206, 229, 242, 246, 264, 285, 304, 333], 'DMSO': [113], 'cisplatin': [115, 166, 193, 294, 405], 'controls.': [117], 'IC50': [118, 230], 'calculated': [120], 'using': [121], 'CellTiter-Glo': [122], 'luminescent': [123], 'viability': [125], 'assay': [126], 'after': [127], '72': [128], 'hours': [129], 'treatment.': [130], 'A': [131], 'preliminary': [132], 'analysis': [133, 233], '19': [135], 'was': [138, 162, 247, 306], 'undertaken': [139], 'determine': [141], 'whether': [142], 'response': [143, 240], 'associated': [147, 302], 'baseline': [149], 'mutation,': [150], 'expression,': [152], 'copy': [154], 'number': [155], 'variation': [156], 'data.': [157], 'Monotherapy': [158, 258], 'efficacy': [159, 414], 'evaluated': [163, 248, 337], 'sensitive': [167, 196, 213, 223, 406], 'A2780': [168, 253], 'vivo': [170, 255, 328, 412], 'xenograft': [171, 256, 329], 'mouse': [172], 'model.': [173, 257], 'Results:': [174], 'Screening': [175], 'demonstrates': [180, 286, 397], '3-log': [182], 'range': [183], 'sensitivity': [185, 287, 305, 398], 'IC50s': [188, 207], 'ranging': [189], 'from': [190, 269], '38-593nM.': [191], 'Simultaneous': [192], 'screening': [194], 'identified': [195], 'resistant': [198, 215, 225, 408], 'the': [202, 228, 339, 419], 'same': [203], 'panel.': [204, 320], 'Low': [205], 'observed': [209], 'cisplatin.': [217], 'Cell': [218], 'assigned': [221], 'based': [226], 'on': [227], 'values.': [231], 'Preliminary': [232], 'suggests': [234], 'signature': [237, 299, 314], 'could': [238], 'predict': [239], 'an': [250, 326], 'cancer': [252], 'treatment': [259], '4': [261], 'doses': [262], 'across': [265], '5': [266], '5-': [270], '15-mg/kg': [272], 'weekly': [273], 'regimens': [274], 'provided': [275], 'increasing': [276], 'tumor': [277, 322], 'growth': [278, 323], 'inhibition': [279, 324], 'compared': [280], 'vehicle': [282], 'control.': [283], 'Conclusions:': [284], 'independent': [292], 'sensitivity.': [295], 'An': [296], 'interim': [297], 'that': [300, 403], 'defined': [307], 'plan': [310], 'optimize': [312], 'this': [313], 'larger': [317], 'line': [319], 'Dose-dependent': [321], 'model': [330], 'demonstrated.': [332], 'currently': [335], 'being': [336], 'clinic': [340], '(ClinicalTrials.gov': [341], 'Identifiers:': [342], 'NCT02635672': [343], 'NCT04978779).': [345], 'References:': [346], 'Gabay': [347], '2014.': [350], 'Cold': [351], 'Spring': [352], 'Harb': [353], 'Perspect': [354], 'Med.': [355], '4(6):a014241.': [356], 'Lücking': [357], '2021.': [360], 'J': [361], 'Med': [362], 'Chem.': [363], '64(15):11651-11674.': [364], 'Ramsay': [365], '1984.': [368], 'PNAS.': [369], '81(24):7742-7746.': [370], 'Citation': [371], 'Format:': [372], 'Melanie': [373], 'M.': [374, 379], 'Frigault,': [375], 'Hermes': [376], 'Garban,': [377], 'Joy': [378], 'Greer,': [380], 'Stuart': [381], 'Hwang,': [382], 'Raquel': [383], 'Izumi,': [384], 'Amy': [385], 'J.': [386], 'Johnson,': [387], 'Beatrix': [388], 'Stelte-Ludwig,': [389], 'Ahmed': [390], 'Hamdy.': [391], 'inhibitor,': [396], 'are': [404], 'delivers': [410], '[abstract].': [415], 'In:': [416], 'Proceedings': [417], 'American': [420], 'Association': [421], 'Cancer': [423, 434], 'Research': [424], 'Annual': [425], 'Meeting': [426], '2022;': [427], '2022': [428], 'Apr': [429], '8-13.': [430], 'Philadelphia': [431], '(PA):': [432], 'AACR;': [433], 'Res': [435], '2022;82(12_Suppl):Abstract': [436], 'nr': [437], '1859.': [438]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4282970146', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}], 'updated_date': '2024-09-27T09:58:15.726657', 'created_date': '2022-06-17'}